Drug Promotion - What We Know, What We Have Yet to Learn - Reviews of Materials in the WHO/HAI Database on Drug Promotion - EDM Research Series No. 032
(2004; 102 pages) View the PDF document
Table of Contents
View the documentAcknowledgements
View the documentExecutive summary
Open this folder and view contentsIntroduction
Open this folder and view contentsReview 1. What attitudes do professional and lay people have to promotion?
Close this folderReview 2. What impact does pharmaceutical promotion have on attitudes and knowledge?
View the document2.1 Reported use of promotion as a source of drug information
View the document2.2 Reported use of promotion as a source of information in adopting new medicines
View the document2.3 Impact of promotion on self-reported attitudes and knowledge
View the document2.4 Research designs that aim to avoid the limitations of self-report data
View the documentSummary of conclusions
View the documentDirections for future research
Open this folder and view contentsReview 3. What impact does pharmaceutical promotion have on behaviour?
Open this folder and view contentsReview 4. What interventions have been tried to counter promotional activities, and with what results?
View the documentFinal conclusions
View the documentReferences
 

Summary of conclusions

Promotion influences doctors’ attitudes much more than they realise. They often use it as a source of information about new medicines, and for medicines used outside their usual therapeutic field. Doctors in private practice, or who graduated long ago, report the highest use of promotion as a source of drug information.

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: October 7, 2014